LQDA Stock Analysis: Buy, Sell, or Hold?
LQDA - Liquidia Corporation Common Stock
$84.11
-2.69 (-3.10%)
▼
5d:
-2.45%
30d:
+6.04%
90d:
+114.51%
WAIT
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 12, 2026
9d
Smart Money Distribution
None View Scanner →
Strength: 6.5/10
Get Alerted When LQDA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: LQDA shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: LQDA shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$134.59
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$83.57
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LQDA is currently trading at $84.11, which is considered extended relative to its 30-day fair value range of $75.40 to $84.48. From a valuation perspective, the stock is trading at a premium (Forward PE: 14.5) compared to its historical average (11.9). At these levels, the market is pricing in 6.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, LQDA is in a strong uptrend. Immediate support is located at $76.98, while resistance sits at $91.10. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LQDA is in a strong uptrend. Immediate support is located at $76.98, while resistance sits at $91.10. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$75.40 -
$84.48
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
40.5%
Protect Your Profits
Holding LQDA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.1%)
- NEUTRAL: Near Wall St target ($84.88)
- NEUTRAL: Trading at premium valuation - market expects 6.9% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$75.40 -
$84.48
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$76.98
Resistance Level
$91.10
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
14.48
Wall Street Target
$84.88
(+0.9%)
Revenue Growth (YoY)
4158.5%
Profit Margin
7.7%
Valuation Premium vs History
+6.9% premium
PE vs Historical
14.5 vs 11.9
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.9%
(market-implied from PE analysis)
1-Year Target
$89.91
(+7%)
2-Year Target
$96.12
(+14%)
3-Year Target
$102.75
(+22%)
3-Yr Target (if PE normalizes)
(PE: 14→12)
PE COMPRESSION
$84.43
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 66.9%)
$406.35
(+383%)
Base:
(SPY PE: 14.5, Growth: 66.9%)
$283.87
(+238%)
Bear:
(PE: 11.9, Growth: 66.9%)
$233.26
(+177%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (22x PE), but valuation improves significantly next year (14x PE) as earnings recover.
Forward PE: 21.88 | Forward EPS (Implied): $3.84
Bull Case
$101.56
(+21%)
Analyst growth 15.0%, PE expands to 23.0
Base Case
$84.11
(0%)
Market implied 0.0%, PE stable at 21.9
Bear Case
$64.34
(-24%)
Severe decline -15.0%, PE contracts to 19.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 02, 2026 5:35 PM ET
Data refreshes hourly during market hours. Next update: 6:35 PM
Data refreshes hourly during market hours. Next update: 6:35 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LQDA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
19
Sells
Net
INSIDERS SELLING
Recent Transactions
Roger Jeffs
SELL
18839 shares
2026-04-17
Michael Kaseta
SELL
139390 shares
2026-04-15
Roger Jeffs
SELL
25000 shares
2026-04-15
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$211 | 60 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$112 | 52 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$663 | 48 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$113 | 45 HOLD |
|
AVDL
Avadel Pharmaceuticals P… |
STRONG BUY
8 analysts |
$21 | 62 BUY |
Advanced LQDA Option Strategies
Professional options setups generated by AI based on today's LQDA price and gamma walls.